VREOF - Vireo Health International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 537.06M
Enterprise Value 3108.19M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.80
Price/Book (mrq)1.15
Enterprise Value/Revenue 35.26
Enterprise Value/EBITDA 611.36

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 32.33%
52 Week High 35.0626
52 Week Low 31.5000
50-Day Moving Average 32.1420
200-Day Moving Average 33.1031

Share Statistics

Avg Vol (3 month) 329.32k
Avg Vol (10 day) 342.33k
Shares Outstanding 5N/A
Float 22.3M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -21.86%
Operating Margin (ttm)43.36%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)20.56M
Revenue Per Share (ttm)6.68
Quarterly Revenue Growth (yoy)57.10%
Gross Profit (ttm)16.78M
EBITDA 9.53M
Net Income Avi to Common (ttm)-4.49M
Diluted EPS (ttm)-1.4600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.4M
Total Cash Per Share (mrq)0.52
Total Debt (mrq)17.3M
Total Debt/Equity (mrq)15.83
Current Ratio (mrq)9.20
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)-10.38M
Levered Free Cash Flow (ttm)N/A